DCBCI-2203

N/A

Report date: 2024/12/12 11:19:21
NME

Base Information

Drug NameDCBCI-2203
Drug Alias NameDCBCI2203DCBCI-2203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKRAS G12D degradersKRAS G12V degraders
TargetsKRAS G12DKRAS G12V
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Research Institute Of Chinese Medicine, Ministry Of Health And Welfare
China Registration ClassN/A

Develop Information

Active CompaniesNational Research Institute Of Chinese Medicine, Ministry Of Health And Welfare
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A